Treatment of the patient with primary familial heterozygous hypercholesterolemia.
Familial heterozygous hypercholesterolemia (FH) is a genetically linked lipid disorder that involves elevations in total cholesterol and LDL cholesterol. About 5% of patients with coronary heart disease have FH. Treatment options include dietary therapy, weight optimization, exercise, and drug treatment. A case study of a patient who has undergone 4 years of treatment for FH after a diagnosis of coronary heart disease is presented. Nursing care was instrumental in the patient's compliance with and adherence to the treatment plan.